Vikas Sinha, Director at Verona Pharma plc (VRNA), sold 160,000 shares at $9.39 ($1.5M) on 2025-05-20, disclosed to the SEC on 2025-05-22.
Scheduled sale ($1.5M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VRNA | SELL | 2025-08-05 | $114K | — | Filing → |
| VRNA | SELL | 2025-05-22 | $2.9M | — | Filing → |
| VRNA | SELL | 2025-05-01 | $178K | — | Filing → |